Best Doctors for Bone Marrow Transplant in India

Dr. Vinod Raina is a distinguished figure in the field of Medical Oncology in India, with over 40 years of exemplary experience. He is currently associated with Fortis Memorial Research Institute in Gurugram, where he functions as the Chairman and Head of Medical Oncology and Hematology. His primary expertise lies in chemotherapy treatment and he was the first to perform high-dose chemotherapy in India. He also performed the first peripheral blood BMT in India — milestones that placed him at the frontier of oncology practice in the country during a period when these techniques were only available in the most advanced centres globally. Dr. Raina possesses specialised expertise in treating a wide spectrum of cancers including breast cancer, lung cancer, gastrointestinal cancer, urological cancer, gynaecological cancer, lymphoma, and myeloma. His contributions extend to performing approximately 400 BMTs, significantly enhancing treatment options for various cancers in India. Before joining Fortis, Dr. Raina was part of other renowned cancer hospitals such as the All India Institute of Medical Sciences (AIIMS), where during the last decade he performed the largest number of cancer-related transplants in India. He served as a Professor and Head of Medical Oncology at AIIMS, New Delhi, where he garnered immense respect for his knowledge and leadership. Throughout his career, Dr. Raina has worked across hospitals and medical institutes both in India and abroad. During his stint at AIIMS, he was the Principal Investigator of over 50 projects where he showcased his commitment to advancing oncology through rigorous scientific inquiry. He also co-founded the INDOX network, furthering collaborative research efforts in oncology. Moreover, he has been conducting the DM course for Medical Oncology for the last 15 years and has trained more than 70 residents and DM students at AIIMS, many of whom now occupy prominent positions in the field globally. He holds more than 200 publications in national and international medical journals worldwide.

Dr. J. Jebasingh is a Senior Consultant in Medical Oncology at the Cancer Centre of Rela Institute & Medical Centre in Chennai, India, with more than 33 years of clinical expertise in comprehensive cancer care. He holds a DM in Medical Oncology from Madras Medical College (2006), an MD in Radiotherapy from Madurai Medical College (1999), a DNB in General Medicine from Meenakshi Mission Hospital & Research Centre (2000), and an MBBS from the prestigious Christian Medical College (1993). His deep foundation across radiotherapy, general medicine, and medical oncology positions him uniquely to manage complex malignancies with integrated, evidence-based approaches. Dr. Jebasingh specializes in chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapies for breast, gynecologic, and prostate cancers. He brings particular expertise in bone marrow transplantation and emerging CAR-T cell therapy. His clinical career has been enriched by active participation in rigorous clinical trials, including bio-equivalence studies of liposomal doxorubicin and temozolomide, and maintenance pemetrexed protocols in non-squamous lung cancer. He has presented findings at nearly 40 international and regional oncology conferences and has authored research on nasopharyngeal cancer, neo-adjuvant response assessment in osteosarcoma, and glucose tolerance outcomes in cancer populations. This combination of bedside practice and investigative rigor ensures his patients benefit from the latest therapeutic advances. Dr. Jebasingh has trained extensively in specialized oncology domains, including bone marrow transplantation at Cancer Institute, Adyar, and pediatric and gynecological oncology at the Institute of Child Health and Institute of Obstetrics & Gynaecology, Chennai. He maintains currency through continuing medical education, having completed a Johns Hopkins University certification on breast cancer updates. He welcomes international patients from the Gulf, Africa, and South Asia, offering compassionate, personalized cancer management with fluency in English, Hindi, and Tamil. His holistic approach integrates supportive care alongside curative and palliative strategies. Rela Institute & Medical Centre is one of India's leading multi-specialty hospitals, accredited by JCI and NABH, with state-of-the-art oncology facilities, dedicated ICU support, and an established international patient services desk. The hospital's cancer centre combines cutting-edge diagnostic imaging, advanced chemotherapy infusion units, and hematology-oncology laboratories. For international patients, the hospital arranges rapid visa documentation support, accommodation coordination, and flexible telemedicine follow-ups. Dr. Jebasingh's 33+ years of dedicated oncology practice, combined with Rela's world-standard infrastructure and patient-centric services, makes Chennai an increasingly preferred destination for complex cancer care among patients across Asia, the Middle East, and Africa.

Dr. Nitin Sood is Vice Chairman of the Hematology department at Medanta — The Medicity in Gurgaon, one of India's leading tertiary-care institutions. With over 28 years of clinical experience, he is a highly trained hematologist and medical oncologist holding advanced qualifications including FRCPath, MRCPath, and MRCP (UK). His credentials reflect a rigorous educational pathway: MBBS from Mysore University (1998), MD in General Medicine and DNB in Internal Medicine from Delhi University (both 2002), and specialized training in clinical hematology through a CCT qualification completed in the United Kingdom. Dr. Sood's clinical expertise spans the full spectrum of hematologic malignancies and benign blood disorders. He has extensive experience managing acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. He is particularly skilled in bone marrow and stem cell transplantation, including haploidentical transplant approaches, as well as the management of bleeding and clotting disorders, hemophilia, sickle cell disease, thalassemias, and aplastic anemia. His practice reflects both diagnostic acumen and therapeutic sophistication, supported by high patient volumes and contemporary clinical protocols. Dr. Sood regularly treats patients from across the Gulf region, Africa, and the broader international community who seek specialized hematology and oncology care. His fluency in English and Hindi, combined with Medanta's robust international patient services, ensures seamless communication and coordinated care for overseas patients. He understands the complexities of traveling for treatment and tailors clinical schedules and follow-up arrangements accordingly. Medanta — The Medicity is accredited by NABH and JCI, with state-of-the-art hematology laboratories, dedicated stem cell transplant units, and on-site oncology services. The hospital's location in Gurgaon provides excellent connectivity via Delhi, and the institution maintains dedicated international patient coordinators who assist with visa facilitation, accommodation, and treatment logistics. For international patients seeking expert hematology and oncology care in India, Dr. Sood's profile at Medanta represents a compelling combination of clinical depth, institutional infrastructure, and patient-centered support.

Dr. Dharma Choudhary is Chairman of Haemato-Oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital in New Delhi, bringing over 23 years of clinical expertise in blood disorders and transplant medicine. He holds a DM in Clinical Haematology from AIIMS New Delhi and is a life member of the Indian Society of Haematology & Transfusion Medicine, as well as a member of the American Society of Blood and Marrow Transplant. His academic foundation spans fellowships at leading centres including Christian Medical College Vellore, Sanjay Gandhi Post Graduate Institute Lucknow, and the BC Cancer Agency in Vancouver, establishing him as a globally trained specialist. Dr. Choudhary has performed over 2,000 bone marrow transplants, making him one of India's most accomplished transplant surgeons. His clinical repertoire encompasses allogeneic, autologous, and haploidentical transplants, alongside matched sibling donor transplantation. He treats acute leukaemias, myelodysplastic syndromes, bone marrow failure syndromes, and solid tumour chemotherapy with equal proficiency. His systematic approach to patient evaluation and post-transplant care has built a reputation for achieving strong clinical outcomes in complex haematological malignancies. International patients from the Gulf states, Africa, and South Asia regularly travel to New Delhi for Dr. Choudhary's consultation and transplant programmes. He manages the full treatment journey—from initial diagnosis and donor evaluation through long-term follow-up—and works closely with Gaf Healthcare to streamline referrals, arrange local accommodation, and provide interpreter support for non-Hindi-speaking patients. His compassionate communication style and willingness to discuss alternative treatment options make him a trusted advisor for families facing challenging blood disorders. BLK-Max Super Speciality Hospital is one of India's premier multi-specialty centres with NABH accreditation, dedicated bone marrow transplant ICU facilities, and a robust international patient services desk. The hospital's proximity to Delhi's international airport and its established infrastructure for managing complex transplant cases make it a natural hub for medical tourism in haemato-oncology. Dr. Choudhary's leadership position ensures that international patients receive coordinated care with access to allied specialists, diagnostic imaging, and transfusion medicine under one roof, reducing logistical fragmentation and improving treatment continuity.

Dr. Julius Xavier Scott is a distinguished paediatric hemato-oncologist and Director of the Department of Paediatric Hemato-Oncology at Rela Hospital, Chennai. With over 22 years of clinical experience, he brings exceptional expertise in managing complex blood disorders and cancers in children. He holds advanced qualifications including an MD in Paediatrics, DNB (Paediatrics), and a Fellowship in Paediatric Hemato-Oncology from the Women's and Children's Hospital in Adelaide, Australia, ensuring his practice reflects both Indian and international standards of care. Dr. Scott's clinical repertoire encompasses the full spectrum of paediatric haematological and oncological conditions: childhood leukaemias, lymphomas, solid tumours, bone marrow transplantation, retinoblastoma, aplastic anaemia, thalassaemia, sickle cell disease, and immunodeficiency disorders. He has authored over 140 peer-reviewed publications and contributed multiple chapters to leading textbooks in his field. His educational leadership extends through annual refresher courses that train over 500 junior doctors, reflecting his commitment to advancing paediatric oncology practice across India. International patients from across the Gulf region, Africa, and South Asia regularly seek Dr. Scott's care for complex cases requiring specialist management and a compassionate approach. At Rela Hospital, he combines cutting-edge treatment protocols with holistic palliative care, ensuring families receive comprehensive support throughout the child's journey. His work has been recognized with awards including the Best Doctor Award from the Rotary Club of Chennai Towers (2013) and the International Healthcare Award (2016). Rela Hospital, where Dr. Scott practises, is a leading multi-specialty centre in Chennai equipped with advanced haematology and oncology units, a dedicated paediatric ICU, and modern bone marrow transplant facilities. The hospital maintains NABH accreditation and provides coordinated care through an international patient services desk. For families seeking expert paediatric blood and cancer care with a blend of Indian clinical excellence and global best practice, Dr. Scott's team at Rela Hospital offers a trusted destination with proven outcomes and compassionate family-centred care.

Dr. Naidu N. Bethune is a Senior Consultant Medical Oncologist with over 21 years of clinical experience in comprehensive cancer management. He holds a DM in Medical Oncology from Nizam's Institute of Medical Sciences, Hyderabad, an MD in Internal Medicine from Kasturba Medical College, Manipal, and an MBBS from the same institution. His extensive training and specialization position him as a trusted oncology specialist across the Indian subcontinent and internationally. Dr. Bethune's clinical expertise spans a broad spectrum of cancer types and advanced therapeutic modalities. He is proficient in conventional chemotherapy, targeted cancer therapy, and cutting-edge immunotherapy approaches. His practice also encompasses stem cell transplantation and bone marrow transplantation, allowing him to manage both solid tumors and hematological malignancies with comprehensive care. His key clinical areas include breast cancer, lung cancer, gynecological cancers, gastrointestinal malignancies, head and neck cancers, and blood-related cancers, with a special interest in hormone therapy for breast cancer and bleeding disorders. International patients from the Gulf region, Africa, and South Asia regularly seek Dr. Bethune's consultation through Gaf Healthcare. His compassionate approach, combined with his accessibility and willingness to provide immediate guidance during critical situations, has earned him exceptional patient satisfaction ratings. He is fluent in English, Hindi, and Telugu, facilitating seamless communication with diverse patient populations across multiple regions. Dr. Bethune practices at Yashoda Hospitals, Hi-Tech City in Hyderabad, a leading multispecialty healthcare institution known for its world-class oncology department and patient-centric care. The hospital is equipped with advanced diagnostic and therapeutic facilities, making it an ideal destination for international cancer patients seeking expert medical attention. Yashoda's commitment to quality care and its international patient services team ensure that patients from abroad receive comprehensive support throughout their treatment journey. For international patients considering cancer treatment in India, Dr. Bethune offers a combination of clinical excellence, personalized care, and access to advanced therapies at a fraction of the cost in Western countries. Gaf Healthcare facilitates seamless consultations, document reviews, and treatment coordination, enabling patients worldwide to benefit from his expertise without geographical barriers.

Dr. Karanam Ashok Kumar is a Senior Consultant Haemato-Oncologist and Bone Marrow Transplant Specialist at Yashoda Hospitals, Hyderabad, one of India's leading centres for complex hematological malignancies. With more than 21 years of clinical practice, he holds an MBBS from S.V. Medical College Tirupati, a DNB in Medical Oncology and a DM in Clinical Hematology from the prestigious Nizam's Institute of Medical Sciences, Hyderabad, complemented by advanced post-doctoral training at Christian Medical College, Vellore. His deep expertise in hemato-oncology and transplantation medicine has made him a recognised authority in the field. Dr. Ashok Kumar has personally conducted over 400 bone marrow transplants spanning autologous, allogeneic, and haploidentical procedures in both adult and paediatric populations. His clinical practice encompasses acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, thalassaemia, sickle cell disease, aplastic anaemia, and amyloidosis. He combines rigorous diagnostic precision with innovative treatment protocols, ensuring optimal outcomes even in complex and rare haematological disorders. His work at the Mehdi Nawaj Jung Regional Cancer Center further expands his capacity to manage the most challenging cases. Dr. Ashok Kumar has earned international recognition through his management of patients from across the Gulf Region, Africa, and South Asia. He is fluent in English, Hindi, and Telugu, making him accessible to diverse patient populations. His patient-centric approach ensures thorough counselling, transparent treatment planning, and compassionate care throughout the transplantation journey and long-term follow-up. Many international patients choose his care for the combination of technical excellence and personalised attention. Yashoda Hospitals, Somajiguda, Hyderabad, is equipped with state-of-the-art haemato-oncology and transplantation units, advanced diagnostic laboratories, and dedicated isolation facilities essential for bone marrow transplant recipients. The hospital maintains rigorous infection control protocols and offers seamless coordination for international patients, including visa assistance, accommodation guidance, and multilingual support staff. Hyderabad's robust medical infrastructure and cost-effective treatment make it an attractive destination for international patients seeking world-standard care at accessible rates. For international patients considering bone marrow transplantation or complex haemato-oncology treatment, Dr. Ashok Kumar's combination of advanced training, high transplant volumes, and proven outcomes offers both safety and success. His association with major professional bodies—the Indian Society of Blood and Marrow Transplantation and the Asia Pacific Society of Blood and Marrow Transplantation—reflects his commitment to evidence-based practice and continuous professional development. Gaf Healthcare facilitates seamless consultation and treatment coordination for patients worldwide.

Dr. Rajeev Vijayakumar is the Head of Department and Senior Consultant in Medical Oncology at Gleneagles Hospitals, Bengaluru, one of India's leading multispecialty centers. With over 20 years of clinical experience, he has established himself as a trusted specialist in the diagnosis and management of blood cancers, solid tumors, and complex hematological disorders. His credentials span both India and the United Kingdom, including MRCP certification and ESMO (European Society for Medical Oncology) accreditation, reflecting his commitment to global oncological standards. Dr. Rajeev's clinical depth extends across a comprehensive range of advanced cancer therapies. He specializes in hemato-oncology, bone marrow transplantation, conventional chemotherapy, cancer immunotherapy, targeted molecular therapy, CAR-T cell therapy, and hormone therapy for breast cancer. His approach combines evidence-based protocols with personalized treatment planning, ensuring each patient receives care tailored to their tumor biology and clinical profile. The breadth of his expertise allows him to manage both common and rare malignancies with equal proficiency. Dr. Rajeev has developed a reputation for welcoming and expertly managing international patients from across the Gulf, Africa, and Southeast Asia. He understands the unique logistical and emotional needs of patients traveling for cancer care and ensures seamless coordination from initial consultation through follow-up. His multilingual capabilities—English, Hindi, and Kannada—facilitate clear communication with diverse patient populations. Patients consistently praise his ability to transform medical consultations into meaningful dialogues where concerns are heard and treatment options are explained with clarity and compassion. Gleneagles Hospitals Bengaluru is a NABH-accredited, 350-bed multispecialty facility equipped with advanced diagnostic and therapeutic technologies, including cutting-edge oncology suites, dedicated hemato-oncology units, and state-of-the-art intensive care. The hospital's international patient services desk coordinates visa support, accommodation, and travel logistics, making it an ideal destination for cancer patients seeking world-standard care in India. Dr. Rajeev's leadership within this infrastructure ensures that international patients benefit from both his individual expertise and the hospital's comprehensive oncological ecosystem. For patients from the Middle East, Africa, and SAARC regions seeking specialized cancer care, Bengaluru offers cost-effective, high-quality treatment without geographical compromise.

Dr. Padmaja Lokireddy is a Consultant Haematologist and Hemato-Oncologist with over 18 years of clinical experience in diagnosing and treating blood disorders and hematologic malignancies. She holds advanced international qualifications including MRCP (Member of the Royal College of Physicians) and FRCPath (Fellow of the Royal College of Pathologists), reflecting her rigorous training in internal medicine and hematology. Her credentials span specialty training in both the United Kingdom's National Health Service and leading Indian institutions, positioning her as a trusted authority in blood disease management. Dr. Lokireddy specializes in the diagnosis and treatment of acute leukemia, bone marrow transplantation, hemophilia, chronic thrombocytopenia, myelodysplastic syndromes, sickle cell disease, and bone marrow failure syndromes. She also offers expertise in chemotherapy and immunotherapy for advanced cancers, coagulation disorders, and transfusion medicine. Her clinical practice is grounded in evidence-based protocols and individualized treatment planning, ensuring each patient receives care tailored to their specific condition and circumstances. With a patient-centered approach, Dr. Lokireddy welcomes international patients from the Gulf region, Africa, and beyond who seek specialized hematologic care. She is fluent in English, Hindi, and Telugu, facilitating clear communication with diverse patient populations. Her experience managing complex blood disorders in both adult and pediatric patients, combined with her academic contributions and published research, has earned her recognition among international physician networks. She is registered with the General Medical Council (United Kingdom), the Royal College of Pathologists, and the Telangana Medical Council, ensuring compliance with the highest professional standards. Dr. Lokireddy practices at Apollo Hospital, Jubilee Hills, Hyderabad, a leading multi-specialty institution equipped with advanced hematology laboratories, oncology centers, and bone marrow transplant facilities. Apollo Hospital is accredited by NABH and maintains international standards for patient safety and clinical excellence. The hospital's dedicated international patient services team assists with visa documentation, accommodation, and treatment coordination, making it an accessible destination for patients traveling from across the globe. Hyderabad has emerged as a major medical-tourism hub in India, known for its combination of world-class healthcare infrastructure and cost-effectiveness. International patients choosing Dr. Lokireddy benefit from her international training, rigorous credentialing, and access to comprehensive diagnostic and therapeutic resources.

Dr. Ponni Sivaprakasam is a Senior Consultant in Medical Oncology at Gleneagles Global Health City in Chennai, bringing over 17 years of clinical expertise in cancer care and blood disorders. She holds an MRCPCH qualification from the Royal College of Paediatrics and Child Health, London, and has completed specialized fellowships in clinical pediatric hematology-oncology and bone marrow transplantation from leading UK institutions including The Hospital for Sick Children and Bristol Royal Hospital for Children. Her international distinction includes recognition as a JACIE inspector by the European Blood and Marrow Transplantation group, a role that involves inspecting and accrediting bone marrow transplant centers worldwide to maintain global quality standards. Dr. Sivaprakasam's clinical practice encompasses the full spectrum of medical oncology, with particular expertise in pediatric hemato-oncology, bone marrow and stem cell transplantation, chemotherapy protocols, cancer immunotherapy, and targeted therapies including CAR-T cell therapy. She has published peer-reviewed research in high-impact journals on mesenchymal stromal cell therapy for graft-versus-host disease and adenovirus infection in transplant recipients, demonstrating her engagement with advancing cancer and transplant medicine. Her case management spans complex pediatric and adult cancer patients, and she leads multidisciplinary teams in treatment planning and long-term follow-up care. International patients from the Gulf, Africa, and South Asia find Dr. Sivaprakasam's clinic a welcoming environment. She communicates fluently in English, Hindi, and Tamil, and her experience managing cross-border patient logistics is substantial. Patients appreciate her systematic approach to diagnosis, evidence-based treatment planning, and transparent communication about prognosis and options. The clinic coordinates closely with Gaf Healthcare to arrange remote consultations, medical record review, and seamless admission processes for patients traveling to Chennai for treatment. Gleneagles Global Health City is a JCI-accredited, multi-specialty tertiary care facility with dedicated oncology and transplant units, advanced diagnostic imaging, and on-site blood bank facilities. The hospital's international patient services team manages visa support, accommodation liaison, and currency exchange for overseas visitors. The institution's commitment to evidence-based practice and infrastructure for complex cancer care makes it an established choice for international patients seeking comprehensive oncology management in South India. International patients should know that Dr. Sivaprakasam's clinic operates with clear pathways for virtual consultation, document review prior to travel, and pre-treatment planning. Treatment timelines and costs are discussed openly, and follow-up care can be coordinated with local oncologists after the patient returns home. Chennai's modern airport connectivity and lower cost of care compared to Western centers make it an accessible option for families managing serious cancer diagnoses.

Dr. Arun Ramanan V is Clinical Lead and Senior Consultant in Medical Oncology at Gleneagles HealthCity Chennai, one of India's leading cancer care institutions. With over 16 years of clinical experience, he holds a DM (Medical Oncology) from Madras Medical College and is a Fellow of the Indian Academy of Palliative Medicine (FIPM). His clinical expertise spans comprehensive cancer management, including chemotherapy for solid and haematologic malignancies, bone marrow transplantation, immunotherapy, targeted therapy, and advanced radiotherapy techniques. Dr. Arun Ramanan has served as Principal Investigator in multiple Phase II–IV clinical trials involving immunotherapies, biosimilars, and targeted therapies, bringing cutting-edge evidence-based treatment to his patients. His specialization includes breast cancer oncology, lung cancer oncology, gastrointestinal malignancies, and personalized precision medicine. He has published eight original research articles and two case reports in reputed national and international journals, demonstrating his commitment to advancing oncology knowledge and clinical practice. International patients from the Gulf countries, East Africa, and South Asia increasingly seek his care for complex and rare cancers. Dr. Arun Ramanan combines his extensive clinical acumen with a compassionate, patient-centered approach. He is fluent in English, Hindi, and Tamil, and actively mentors postgraduate fellows and conducts regular continuing medical education programs. His recognition as "Best Doctor" by the Government of Tamil Nadu in 2022–2023 and 2023–2024 underscores his clinical excellence and community trust. Gleneagles HealthCity Chennai, located in Perumbakkam, is a NABH-accredited multispecialty institution equipped with state-of-the-art oncology departments, advanced imaging, and dedicated international patient services. The hospital's tumour board approach and multidisciplinary team ensure every patient receives integrated, evidence-based care. For international patients, the hospital provides comprehensive visa assistance, accommodation coordination, and medical record translation services, making cancer care accessible and stress-free.

Dr. Vishnu Hari is an Associate Director and Head of Unit I in Medical Oncology, Haematology, and Bone Marrow Transplantation at Sarvodaya Hospital in Faridabad. With more than 16 years of clinical experience, he brings deep expertise in diagnosing and treating a broad spectrum of solid and haematological malignancies. His comprehensive training at the Regional Cancer Centre, Trivandrum, combined with his qualifications in internal medicine and general medicine from Government Medical College, Calicut, has established a strong academic and clinical foundation. Dr. Hari's clinical proficiency encompasses the management of leukaemia, lymphoma, myeloma, breast cancer, sarcoma, gastrointestinal cancers, and genitourinary cancers. He is highly skilled in advanced treatment modalities including stem cell transplantation, cancer immunotherapy, targeted therapy, CAR-T cell therapy, and precision oncology. His expertise in oncology critical care ensures that patients with complex presentations receive comprehensive, multidisciplinary support throughout their treatment journey. International patients from the Gulf region, Africa, and South Asia seek Dr. Hari's care for complex oncology cases. He maintains a patient-centric approach, taking time to explain treatment options in clear language and ensuring families understand the clinical pathway. His experience treating international patients has equipped him with cultural sensitivity and a commitment to coordinating care seamlessly across borders. Sarvodaya Hospital, located in Sector 8 of Faridabad, is an established tertiary cancer centre with state-of-the-art oncology facilities, dedicated haematology-BMT units, and comprehensive critical care infrastructure. The hospital prioritizes international patient support with dedicated consultation coordinators, translation services, and streamlined admission processes. Patients from overseas benefit from the hospital's integration of global treatment protocols with local expertise, making complex cancer care both accessible and affordable. International patients considering treatment in India should know that Dr. Hari's unit maintains standards aligned with ASCO and ESMO guidelines, ensuring evidence-based care regardless of origin. Gaf Healthcare can facilitate initial video consultations, arrange document reviews, and coordinate logistics for international patients seeking second opinions or comprehensive oncology management.

Dr. Jimmy Mirani is a Senior Consultant in Medical Oncology with over 15 years of clinical expertise in diagnosing and treating a comprehensive range of cancers. He holds an MBBS, MD in Internal Medicine, and completed his advanced super-specialty qualification (MCH in Medical Oncology) at Tata Memorial Hospital, Mumbai — one of India's most prestigious cancer centres. His extensive training at this renowned institution has equipped him with deep knowledge of evidence-based oncology and patient-centered care. Dr. Mirani's clinical practice encompasses the full spectrum of modern cancer treatment modalities. He specializes in medical oncology, hemato-oncology, bone marrow transplantation, and the delivery of sophisticated chemotherapy regimens. His expertise extends to cutting-edge approaches including cancer immunotherapy, targeted molecular therapy, and hormone-based treatments for breast and prostate cancers. He combines rigorous clinical judgment with the latest treatment protocols to deliver individualized care plans for each patient, regardless of cancer type or complexity. Dr. Mirani has built a strong reputation for treating international patients, welcoming referrals from the Gulf region, Africa, and across South Asia. He is skilled in communicating complex oncology concepts in a patient-friendly manner and works closely with families throughout the treatment journey. His commitment to compassionate, outcome-focused care has earned him a 4.9-star rating across 190 patient reviews, reflecting consistent trust and satisfaction. Based at Gleneagles Hospital Mumbai, Dr. Mirani benefits from a world-class infrastructure with state-of-the-art oncology wards, advanced imaging and pathology services, and comprehensive supportive care facilities. Gleneagles Mumbai is well-equipped to manage international patients, offering multilingual staff, medical visas support, and coordination of pre- and post-treatment follow-up. Dr. Mirani is an active member of the European Society for Medical Oncology (ESMO) and serves as faculty and invited speaker at national and international oncology conferences, keeping his knowledge current with global best practices. International patients choosing Dr. Mirani benefit from his decades of experience, access to India's leading cancer centre infrastructure, and a consultation fee of just USD 65, making comprehensive oncology care accessible while maintaining the highest clinical standards.

Dr. Harish Kancharla is a Consultant Medical Oncologist and Hemato-Oncologist at Yashoda Hospitals in Hyderabad, India, with over 14 years of clinical experience in comprehensive cancer care. He holds a DM in Medical Oncology from AIIMS Delhi (where he secured All India 1st Rank in the DM/MCh Entrance Examination) and an MD in Internal Medicine from PGIMER Chandigarh, alongside his MBBS from Gandhi Medical College, Hyderabad. His training at India's premier medical institutions has established him as a trusted authority in oncology. Dr. Kancharla's clinical expertise spans the full spectrum of solid tumours and haematological malignancies, with particular depth in gastrointestinal cancers, head and neck malignancies, urogenital cancers, breast cancer, thoracic oncology, sarcomas, and leukaemias. He is proficient in modern treatment modalities including conventional chemotherapy, cancer immunotherapy, targeted molecular therapy, hormone therapy, and bone marrow transplantation. His approach integrates evidence-based protocols with individualised patient management, and he regularly presents his clinical outcomes and research findings at national and international oncology conferences. Dr. Kancharla has built a strong reputation for treating international patients from across the Gulf region, Africa, and South Asia. He is fluent in English, Hindi, and Telugu, ensuring clear communication with diverse patient populations. His consultations are supported by Gaf Healthcare's comprehensive patient coordination services, including medical document review, video conferencing, and seamless care transition. Patients appreciate his patient-centred approach, clinical thoroughness, and commitment to explaining complex treatment options in accessible language. Yashoda Hospitals, where Dr. Kancharla practices, is a leading multispecialty tertiary care institution recognised for its oncology division, advanced diagnostics, and international patient services. The hospital combines modern infrastructure with a collaborative care model, ensuring patients receive coordinated support from surgery, radiation, and medical oncology teams. For international patients seeking specialist cancer care in India, Yashoda Hospitals provides a trusted destination with NABH accreditation, dedicated international patient facilitation, and transparent treatment pathways. Dr. Kancharla is an active member of the European Society for Medical Oncology (ESMO), the International Association for the Study of Lung Cancer (IASLC), and the Indian Cooperative Oncology Network (ICON), reflecting his commitment to maintaining global best practice standards. International patients can confidently engage with Dr. Kancharla knowing they will receive world-standard oncology care delivered in a welcoming, English-speaking environment with full support for travel, accommodation, and post-treatment follow-up.

Dr. Govind Eriat is a Visiting Consultant in Hematology and Hemato-Oncology at Gleneagles Hospitals, Bengaluru, bringing over 14 years of specialized clinical experience in blood disorders and cancer care. He holds an MBBS degree and has completed his DNB in Internal Medicine, establishing a strong foundation in comprehensive patient care. His international credentials include Fellowship from the Royal College of Physicians (FRCP), United Kingdom, and a prestigious Fellowship in Leukemia and Bone Marrow Transplantation from Vancouver, Canada—qualifications that reflect his commitment to world-standard hematological practice. Dr. Eriat's clinical expertise encompasses the full spectrum of hematological malignancies and blood disorders. He specializes in bone marrow transplantation (BMT), autologous stem cell transplantation (ASCT), haploidentical BMT, and treatment of acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. His approach combines evidence-based protocols with personalized treatment strategies, ensuring each patient receives comprehensive care tailored to their specific diagnosis and clinical needs. Throughout his career, Dr. Eriat has developed a strong track record treating international patients from across the Gulf region, Africa, and South Asia. He understands the complexities of coordinating care for patients traveling for treatment and maintains open communication with referring physicians worldwide. His fluency in English, Hindi, and Kannada further facilitates seamless interaction with diverse patient populations seeking hematological care in India. Gleneagles Hospitals, Bengaluru is a modern tertiary-care facility well-equipped for complex hematological management, including dedicated oncology wards, advanced laboratory facilities, and infection control protocols essential for immunocompromised patients undergoing transplantation. The hospital's international patient services team supports documentation, visa coordination, and accommodation logistics. For international patients considering BMT or advanced blood cancer treatment, Dr. Eriat's combination of Indian training, North American fellowship experience, and UK-recognized credentials provides reassurance of globally aligned clinical standards.

Dr. Dhaarani J is a Consultant Paediatric Hemato-Oncologist at Dr. Rela Institute & Medical Centre in Chennai, bringing over 13 years of dedicated clinical experience to the care of children with blood disorders and childhood cancers. She holds an MD from PGIMER Chandigarh, one of India's most prestigious medical institutions, and is fellowship-trained by the National Board of Examinations and the Indian Academy of Paediatrics in paediatric hemato-oncology. Her clinical journey spans more than 5 years of independent specialist practice, during which she has developed deep expertise in managing complex haematological and oncological conditions in children. Dr. Dhaarani specializes in paediatric bone marrow transplantation, hematopoietic stem cell transplantation, and the treatment of conditions including paediatric leukemia, thalassemia, sickle cell disease, and aplastic anemia. Her clinical work extends to primary immunodeficiencies and rare paediatric syndromes with genetic and autoimmune underpinnings. She has published over 70 peer-reviewed articles, case reports, and clinical studies, establishing herself as an active contributor to paediatric hemato-oncology literature. In 2023, she served as Organising Secretary of PHOCON, the national conference for paediatric hemato-oncology experts, reflecting her standing within the Indian paediatric oncology community. Dr. Dhaarani regularly treats international patients from the Gulf region, Africa, and South Asia who seek advanced paediatric cancer and blood disorder care. She brings compassionate, family-centered communication and is fluent in English, Hindi, and Tamil, ensuring that families from diverse backgrounds feel supported throughout treatment. Her international patient experience encompasses complex cases requiring long-term follow-up, donor coordination for transplantation, and multidisciplinary symptom management. At Dr. Rela Institute & Medical Centre, a NABH-accredited tertiary care facility in Chennai, Dr. Dhaarani benefits from state-of-the-art paediatric oncology infrastructure, dedicated ICU beds, experienced nursing support, and robust coordination for international families. The institute is well-equipped for bone marrow and stem cell transplantation, with seamless integration of supportive care, infectious disease expertise, and nutritional rehabilitation. For international patients and their families, Dr. Rela Institute offers dedicated patient liaison services, English-speaking staff, and accommodation support, making Chennai an accessible destination for paediatric hemato-oncology care.

Dr. Jasmine Porwal is a Consultant in Medical Oncology and Cancer Care at Medanta — The Medicity in Gurgaon, bringing over 12 years of clinical expertise to comprehensive cancer management. She holds a DM in Medical Oncology from the All India Institute of Medical Sciences (AIIMS) in New Delhi, along with an MD in Internal Medicine from PGIMER – Dr. RML Hospital, New Delhi. Her rigorous training in evidence-based oncology and prior experience as a Senior Research Fellow at AIIMS Delhi (Indian Institute of Rotary Cancer Hospital) have shaped her approach to precision cancer care. Dr. Porwal specializes in the management of solid tumours and haematological malignancies, with particular expertise in chemotherapy regimens—both adjuvant and neoadjuvant—as well as modern immunotherapy and molecular targeted therapy. She is skilled in immune checkpoint inhibitor therapy, manages oncological emergencies with clinical acuity, and provides compassionate palliative care tailored to each patient's goals. Her experience also extends to bone marrow transplantation and complex treatment sequencing under both optimal and resource-constrained settings. She has published her clinical research in leading international journals including the Journal of Clinical Oncology, Annals of Oncology, and Blood, reflecting her commitment to advancing cancer treatment outcomes through rigorous clinical investigation. International patients from the Gulf region, Africa, and SAARC countries form a significant part of her practice. Dr. Porwal is fluent in English and Hindi, ensuring clear communication with patients from diverse backgrounds. She takes a patient-centred approach, discussing treatment options transparently and involving families in decision-making. Her clinic at Medanta welcomes patients seeking second opinions, comprehensive staging, treatment planning, and ongoing supportive care for both newly diagnosed and recurrent cancers. Medanta — The Medicity is a NABH and JCI-accredited tertiary care institution in Gurgaon, known for its comprehensive oncology centre with advanced diagnostic imaging, chemotherapy suites, and integrated palliative services. The hospital's international patient desk, dedicated translators, and streamlined admission processes make it a preferred destination for cancer patients across South Asia, the Middle East, and Africa seeking world-standard care at reasonable costs. Dr. Porwal's tenure at premier institutions including Safdarjung Hospital and the National Cancer Institute, Jhajjar, has further refined her expertise in managing complex oncological scenarios and leading clinical trials. Patients choosing Dr. Porwal benefit from her evidence-based, compassionate approach and access to Medanta's state-of-the-art facilities. International patients are advised to connect via Gaf Healthcare to arrange initial video consultations, document review, and streamlined travel and treatment planning for their cancer care journey.

Dr. Neema Bhat is a Consultant Hematologist and Hemato-Oncologist specializing in blood disorders and bone marrow transplantation. With over 12 years of clinical experience, she holds board certifications from the American Board of Hematology and Pediatric Oncology as well as the American Board of Pediatrics, reflecting her rigorous international training and deep expertise across adult and pediatric hematological conditions. Dr. Bhat's clinical practice encompasses the full spectrum of hematological care: from management of chronic anemias and clotting disorders to complex blood malignancies including acute and chronic leukemia, lymphoma, and multiple myeloma. She brings particular expertise in bone marrow transplantation—both allogeneic and autologous—as well as chemotherapy protocols and pediatric conditions such as thalassemia, sickle cell disease, and pediatric aplastic anemia. Her training at Seth GS Medical College and KEM Hospital in Mumbai, combined with board certifications and fellowship credentials, demonstrates her commitment to evidence-based, compassionate hematologic care. International patients from the Gulf region, Africa, and beyond benefit from Dr. Bhat's experience with diverse patient populations and her fluency in English alongside regional languages. She understands the unique needs of medical tourists seeking specialized blood cancer and transplant care, providing detailed consultations and seamless coordination with Gaf Healthcare's international patient services. Dr. Bhat practices at Apollo Hospitals, Bannerghatta Road in Bengaluru—a NABH and JCI-accredited institution renowned for oncology and transplant services. The hospital's advanced ICU facilities, dedicated BMT units, and international patient support teams make it an ideal destination for complex hematological cases requiring extended care. International patients traveling for treatment benefit from Apollo's established protocols for medical tourism, multilingual staff, and proximity to Bengaluru's excellent hospitality and recovery infrastructure.

Dr. Suhail Qureshi is an Additional Director and Unit Head of Medical Oncology at Fortis Hospital, Shalimar Bagh, New Delhi, bringing 11 years of dedicated clinical experience in the diagnosis and treatment of diverse malignancies. He is a highly trained medical oncologist with advanced qualifications from some of India's most respected institutions, including a fellowship in Medical Oncology, Hematology and Bone Marrow Transplantation from Medanta, The Medicity, Gurugram. Dr. Qureshi's clinical expertise spans the full spectrum of cancer care, from chemotherapy for solid tumors and hematologic malignancies to advanced immunotherapy and molecular targeted therapies. He has specialized training in adjuvant and neoadjuvant chemotherapy, palliative oncology, hormone therapies for breast and prostate cancers, and autologous bone marrow transplantation. His comprehensive approach ensures that each patient receives individualized treatment tailored to their cancer type, stage, and overall health status. With a patient-centered philosophy, Dr. Qureshi is experienced in managing international patients seeking oncology care from the Gulf region, Africa, and the SAARC countries. He combines evidence-based treatment protocols with compassionate support, making him a trusted choice for families navigating complex cancer diagnoses. His active engagement with international oncology conferences and contributions to peer-reviewed publications demonstrate his commitment to staying current with evolving treatment paradigms. Fortis Hospital, Shalimar Bagh is a leading tertiary care center in New Delhi, accredited with advanced oncology infrastructure, multimodal imaging, and supportive care facilities. The hospital's international patient services team facilitates seamless coordination for overseas patients, including visa assistance, accommodation guidance, and multilingual support. For international patients choosing treatment in New Delhi, Dr. Qureshi's expertise combined with Fortis's world-class facilities offers comprehensive, accessible cancer care.

Dr. Viraj Nevrekar is a Senior Consultant in Medical Oncology and Hemato-Oncology with over 11 years of dedicated clinical experience in treating complex and advanced cancers. A graduate of the All India Institute of Medical Sciences (AIIMS), New Delhi — one of India's most respected medical institutions — he holds both an MD in Medicine and a DM in Medical Oncology, credentials that reflect his rigorous training in oncological care. His additional ECMO certification from Switzerland underscores his commitment to staying at the forefront of global cancer treatment standards. Dr. Nevrekar brings comprehensive clinical depth across all major oncology disciplines. His practice encompasses bone marrow transplantation, chemotherapy protocols, immunotherapy, targeted therapies, and hormone-based treatments for breast, prostate, and gynecologic malignancies. He manages high-volume patient cases and applies evidence-based clinical judgment to design personalized treatment plans for each patient, ensuring outcomes that balance efficacy with quality of life. International patients — particularly those from the Gulf region, Africa, and Southeast Asia — choose Dr. Nevrekar for his patient-centric approach and clear communication across English, Hindi, and Marathi. He has established strong working relationships with leading corporate hospital networks and maintains alignment with international oncology literature, making him a trusted resource for patients seeking second opinions or comprehensive management of advanced disease. Dr. Nevrekar practices at Gleneagles Global Hospitals in Mumbai's Parel neighborhood, a NABH-accredited facility known for its advanced oncology infrastructure, dedicated cancer care units, and seamless coordination for international patients. The hospital's robust support systems, multilingual staff, and comprehensive diagnostic capabilities make it an ideal destination for patients requiring specialized cancer treatment combined with the comfort of a world-class medical environment. For international patients considering treatment in India, Dr. Nevrekar's combination of elite training, extensive clinical experience, and affordability — with consultation fees at just USD 65 — represents excellent value without compromise on clinical rigor or patient safety.

Dr. Divya Doval is a Senior Consultant in Haemato-Oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital, New Delhi. With over 11 years of clinical experience and an exceptional track record of more than 1,500 successful transplants, she has established herself as a leading bone marrow transplant specialist in India. Her academic credentials include MBBS, MRCPCH from the Royal College of Paediatrics and Child Health (UK), and specialized fellowships in CAR-T Cell Therapy from Royal Marsden Hospital in London and in Haemato-Oncology and Bone Marrow Transplant from BLK Super Speciality Hospital. Dr. Doval's clinical expertise spans the full spectrum of bone marrow transplant procedures, including allogeneic, autologous, and haploidentical transplants with matched sibling and unrelated donors. She is particularly skilled in managing acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, and pediatric conditions such as thalassemia and aplastic anemia. Her proficiency in CAR-T cell therapy represents one of the most advanced immunotherapeutic approaches in hematologic malignancies. Her approach to case selection, donor matching, and post-transplant management reflects both evidence-based protocols and personalized clinical judgment honed over thousands of procedures. International patients from the Gulf region, Africa, and SAARC countries seek Dr. Doval's expertise for complex hematologic and transplant management. She is fluent in English and Hindi, and the hospital provides dedicated international patient support to ensure seamless communication and care coordination. Many patients return for follow-up management, reflecting the trust built through transparency, clinical excellence, and compassionate care. The Centre for Bone Marrow Transplant at BLK-Max has become a preferred destination for families seeking second opinions and definitive transplant intervention. BLK-Max Super Speciality Hospital in New Delhi is a NABH-accredited, multi-specialty tertiary care centre with world-class infrastructure for transplant care. The hospital features dedicated transplant wards with HEPA-filtered isolation units, advanced laboratory facilities for HLA typing and chimerism monitoring, and a robust supportive care team including specialized nutritionists, psychologists, and infectious disease specialists. The Centre for Bone Marrow Transplant operates with modern protocols aligned with international guidelines, and the hospital maintains comprehensive records for long-term follow-up and outcome tracking. For international patients, the hospital's international desk arranges logistics, accommodation liaisons, and coordinated care schedules. When considering bone marrow transplant abroad, international patients should know that Dr. Doval's centre offers transplantation at a cost-effective level compared to Western centres, without compromise on sterility standards, donor selection rigor, or post-transplant follow-up intensity. The hospital's experience with patients from multiple countries has refined protocols for managing time-zone coordination, remote consultations, and ensuring continuity of care upon return home.

Dr. Kirankumar Sajjanshetty is a Consultant Medical Oncologist at Gleneagles Hospitals in Bengaluru with over 10 years of clinical experience in cancer care and hematology. He holds the European Society of Medical Oncology (ESMO) certification in Medical Oncology, demonstrating his commitment to international standards of excellence and evidence-based practice. His qualifications include MBBS, MD in Radiotherapy, and DM in Medical Oncology, providing him with a comprehensive foundation across the spectrum of oncologic care. Dr. Kirankumar's clinical expertise spans solid tumours and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, and gynaecologic cancers. He is proficient in advanced treatment modalities such as chemotherapy, cancer immunotherapy, and molecular targeted therapies. His practice embraces precision oncology through multidisciplinary tumour boards, personalizing treatment protocols for each patient. He also manages hematologic disorders including leukemia, lymphoma, and bone marrow conditions, with particular expertise in bone marrow transplantation. International patients—particularly those from the Gulf region, Africa, and South Asia—choose Dr. Kirankumar for his patient-centric approach and ability to communicate complex oncologic information in an accessible manner. His multilingual capability (English, Hindi, and Kannada) facilitates seamless consultation for diverse patient populations. He ensures comprehensive pre-treatment assessment, clear discussion of options, and ongoing psychological support throughout the treatment journey. Gleneagles Hospitals in Bengaluru is a Joint Commission International (JCI) accredited tertiary care centre with dedicated oncology units, advanced radiotherapy facilities, and strong support services for cancer care. The hospital's infrastructure supports complex procedures including stem-cell transplantation and multimodal cancer therapies. International patients benefit from a dedicated medical tourism desk, English-speaking staff, and streamlined admission processes. Dr. Kirankumar's affiliation with this leading institution ensures patients receive world-standard diagnostic and therapeutic resources. International patients seeking cancer treatment in Bengaluru will find in Dr. Kirankumar a clinician who combines technical expertise with genuine empathy. He takes time to understand each patient's goals and concerns, involves them in shared decision-making, and guides them through every phase of care with transparency and compassion.

Dr. Akash Khandelwal is a distinguished consultant hematologist and hemato-oncologist with over 10 years of clinical expertise in complex blood disorders and hematologic malignancies. As Consultant and Unit Head of the Department of Hematology, Hemato-Oncology, and Bone Marrow Transplant at Fortis Hospital Shalimar Bagh in New Delhi, he brings academic rigor from his DM training at the prestigious All India Institute of Medical Sciences (AIIMS), one of India's foremost medical institutions, combined with profound practical experience in advanced transplant medicine. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants, including autologous stem cell transplants, matched sibling donor, matched unrelated donor, and haploidentical donor procedures. His clinical depth spans the full spectrum of hematologic conditions: acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, thalassemia, sickle cell disease, aplastic anemia, and myeloproliferative neoplasms. He is also experienced in cutting-edge immunotherapy, including CAR-T cell therapy, positioning him at the forefront of modern blood cancer treatment. Dr. Khandelwal treats a substantial number of international patients from the Gulf region, Africa, and South Asia who seek specialized bone marrow transplant and hemato-oncology care in India. His hospital affiliation with Fortis Shalimar Bagh—a major multispecialty center in New Delhi—ensures comprehensive support for complex cases, including dedicated transplant units, advanced diagnostic facilities, and seamless coordination for overseas patients. He also maintains active associations with other leading institutions including BLK-MAX Hospital and Action Balaji Cancer Hospital in New Delhi, further expanding his clinical network. Fortis Hospital Shalimar Bagh is accredited under NABH standards and maintains international protocols for patient care. The hospital offers 24/7 ICU support, state-of-the-art imaging, and dedicated hemato-oncology wards essential for transplant recovery. For international patients, the hospital has a well-established medical tourism desk and provides language support in English and regional languages. Patients traveling to New Delhi for bone marrow transplant or blood cancer treatment benefit from the city's well-connected international airport, accessible accommodation, and robust follow-up care infrastructure. When seeking bone marrow transplant or hemato-oncology consultation in India, Dr. Khandelwal's combination of AIIMS training, high transplant volume, and systematic approach to international patient care makes Fortis Shalimar Bagh a dependable destination. International patients should know that bone marrow transplant timelines typically span 3–4 weeks for donor evaluation and transplant, with post-transplant stay extending to 4–8 weeks depending on complications. Most international patients coordinate their visits through Gaf Healthcare for seamless booking and in-country logistics.

Dr. Devanshee Aakash Shah is an accomplished Medical Oncologist with over 8 years of clinical experience in managing complex cancer cases. She holds an MBBS from BJMC, MD in Internal Medicine, and a DM in Medical Oncology from NHL MMC, complemented by advanced certifications including Harvard Medical School eDiploma in Advanced Management of Oncological Diseases and ESMO certification from the European Society of Medical Oncology. Currently serving as Associate Consultant in Medical Oncology at Paras Hospitals in Gurugram, Dr. Shah brings a comprehensive, evidence-based approach to cancer diagnosis and treatment. Dr. Shah's clinical expertise spans a broad spectrum of oncological conditions, including lung cancer, head and neck cancers, hematological malignancies, breast and gynecological cancers, gastrointestinal cancers, and genitourinary cancers. She specializes in chemotherapy for solid tumors, adjuvant and neoadjuvant chemotherapy, immunotherapy for advanced cancer, immune checkpoint inhibitor therapy, molecular targeted therapy, and biomarker-based treatment protocols. Her proficiency in autologous bone marrow transplantation and multiple myeloma management reflects her depth in complex hematologic malignancies. With ECMO certification and extensive clinical volumes, she combines technical precision with personalized cancer care strategies. Dr. Shah is highly experienced in treating international patients seeking specialized oncology care in India. She welcomes patients from the Gulf region, Africa, and Southeast Asia, offering multilingual support in English and Hindi. Her patient-centered approach emphasizes quality of life, novel treatment protocols, and collaborative care planning. She previously served as Assistant Professor at Tata Memorial Hospital, Mumbai—one of India's foremost cancer research and treatment centers—an experience that strengthened her commitment to clinical excellence and evidence-based practice. Paras Hospitals in Gurugram is a nationally accredited, multispecialty tertiary care center known for its oncology department, advanced diagnostic imaging, and comprehensive cancer support services. The hospital attracts international patients due to its NABH accreditation, experienced oncology team, and cost-effective treatment protocols compared to Western centers. Dr. Shah's affiliation with Paras places her at a hub of cancer care innovation, where she integrates cutting-edge therapies with compassionate patient management. International patients choosing Dr. Shah benefit from world-class oncology expertise at a fraction of the cost available in Europe or North America, combined with personalized follow-up care and seamless coordination through Gaf Healthcare.

Dr. Mehak Trehan is an Associate Consultant in Hemato-Oncology and Bone Marrow Transplant at Fortis Memorial Research Institute, Gurgaon. A Clinical Hematologist and Hemato-Oncologist with over 6 years of professional experience, she brings a distinguished academic background marked by exceptional achievements across all stages of her medical training. Dr. Trehan completed her MBBS (Hons.) as Best Outgoing Student and earned a Gold Medal in her MD in Medicine for academic excellence. She further specialised with a DM in Clinical Hematology from the All India Institute of Medical Sciences (AIIMS), New Delhi — one of India's premier medical institutions — where she was again awarded a Gold Medal for outstanding performance. Dr. Trehan's clinical expertise spans the full spectrum of hematological malignancies and blood disorders. She specialises in treating acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. Her particular clinical focus includes bone marrow transplantation, including haploidentical transplant procedures, chemotherapy for blood cancers, and cancer immunotherapy. She has developed strong technical and clinical competencies in managing complex blood disorders such as thalassemia and sickle cell disease, combining evidence-based medicine with compassionate patient care. Dr. Trehan is committed to serving international patients seeking expert hematologic care. She welcomes patients from the Gulf region, Africa, and the broader SAARC region, providing professional consultation and treatment planning in English and Hindi. Her practice at Fortis Memorial Research Institute positions her to manage both routine and highly complex cases, offering continuity of care and access to advanced diagnostic and therapeutic technologies. She maintains active membership in several prestigious national and international societies, including ASCO, SOHO, ASTCT, ISHBT, and the MHG Group, ensuring her practice remains aligned with global standards in hematology and oncology. Fortis Memorial Research Institute in Gurgaon is a leading multi-specialty tertiary care facility renowned for its haematology and oncology departments. The hospital is equipped with state-of-the-art diagnostic facilities, ICU support, and specialised wards for cancer and transplant patients. Its international patient services desk, NABH accreditation, and track record in managing complex blood cancers make it a preferred destination for patients seeking advanced hematologic care. International patients benefit from coordinated care pathways, dedicated translators, and organised logistics support, ensuring a seamless treatment experience in India.

Dr. Bhaarat is a Consultant Hemato-Oncologist at Medanta — The Medicity in Gurugram, specializing in the diagnosis and treatment of blood cancers and hematological disorders. He holds an MBBS degree, an MD in Medicine, and a DrNB in Clinical Hematology from the prestigious Rajiv Gandhi Cancer Institute & Research Centre, New Delhi (2018–2021), where he trained under nationally recognized hemato-oncologists. His expertise spans the full spectrum of hematological malignancies and benign blood disorders. With over 5 years of clinical experience, Dr. Bhaarat has personally participated in more than 100 bone marrow transplant procedures, including autologous, matched sibling donor (MSD) allogeneic, matched unrelated donor (MUD) allogeneic, and haploidentical haematopoietic stem cell transplants (HSCT). He is proficient in managing acute and chronic leukemia, lymphoma, multiple myeloma, and bone marrow failure syndromes. His procedural skills include bone marrow aspiration and biopsy, lumbar puncture, intrathecal chemotherapy, and comprehensive hematological diagnostics. He completed the Dana-Farber Cancer Institute's Acute Lymphoblastic Leukemia Preceptorship Program, further refining his approach to complex leukemia management. Dr. Bhaarat is known for his patient-centric approach and has built a strong reputation for treating international patients seeking world-standard care in India. He regularly welcomes patients from the Gulf Cooperation Council (GCC) nations, Africa, and South Asian countries, offering comprehensive consultation, treatment planning, and long-term follow-up. His bilingual fluency in English and Hindi ensures clear communication with diverse patient populations, making the medical journey seamless for those traveling to India for specialized hematology and transplant care. Medanta — The Medicity stands as one of India's premier multi-specialty healthcare institutions, featuring state-of-the-art ICU and transplant facilities, NABH accreditation, and an established international patient services team. Located in Gurugram, a major business and healthcare hub near Delhi, the hospital offers convenient access for international travelers and comprehensive support throughout the treatment journey. Patients choosing Dr. Bhaarat benefit from both his specialized expertise and Medanta's world-class infrastructure, making it an ideal destination for those seeking advanced hematology and bone marrow transplant services in South Asia.